No Data
No Data
Earnings Preview: IART to Report Financial Results Pre-market on November 04
Integra LifeSciences Holdings (NASDAQ:IART) Sheds US$54m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Trauma Fixation Device Research Report and Company Analysis 2024-2032 Featuring Zimmer Biomet, Orthofix Medical, B. Braun Meslungen, Stryker, Medtronic, Smith & Nephew, Integra LifeSciences, & Otto - ResearchAndMarkets.com
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $21
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating
No Data
No Data
Money Mover OP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$